Advanced in Secondary Adrenal Insufficiency

Emilia Sbardella

Rome, IT 
Advanced in Secondary Adrenal Insufficiency
Rome, IT 
OverviewLocationsClinical Research

Overview

Emilia Sbardella practices in Rome, Italy. Ms. Sbardella is rated as an Advanced expert by MediFind in the treatment of Secondary Adrenal Insufficiency. Her top areas of expertise are Secondary Adrenal Insufficiency, Addison's Disease, Cushing's syndrome, Hormone Replacement Therapy (HRT), and Orchiectomy.

Her clinical research consists of co-authoring 104 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 2 articles in the study of Secondary Adrenal Insufficiency.

Gender
Female

Locations

Rome, 00161, Italy
Other Locations
Sapienza, Italy
Regina Elena, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Study on New Insights in Remodeling of Endocrine Cardiomyopathies: Intramyocardial, Molecular and Neuroendocrine Assessment in Response to Chronic Inhibition of Cyclic GMP Phosphodiesterase 5A in Cushing's Syndrome
Study on New Insights in Remodeling of Endocrine Cardiomyopathies: Intramyocardial, Molecular and Neuroendocrine Assessment in Response to Chronic Inhibition of Cyclic GMP Phosphodiesterase 5A in Cushing's Syndrome
Enrollment Status: Completed
Publish Date: May 16, 2023
Intervention Type: Drug
Study Drug: Tadalafil
Study Phase: Phase 2
Study on New Insights in Remodeling of Endocrine Cardiomyopathies: ASsessmentt of Intramyocardial, Molecular and NeUroendocrine Parameters in Response to Chronic Inhibition of Cyclic GMP Phosphodiesterase 5A in AcroMegaly
Study on New Insights in Remodeling of Endocrine Cardiomyopathies: ASsessmentt of Intramyocardial, Molecular and NeUroendocrine Parameters in Response to Chronic Inhibition of Cyclic GMP Phosphodiesterase 5A in AcroMegaly
Enrollment Status: Completed
Publish Date: May 12, 2023
Intervention Type: Drug
Study Drug: Tadalafil
Study Phase: Phase 2
View 1 Less Clinical Trial

104 Total Publications

Endocrine and metabolic consequences of childhood-onset craniopharyngioma during the transition age: A literature review by the TALENT study group.
Endocrine and metabolic consequences of childhood-onset craniopharyngioma during the transition age: A literature review by the TALENT study group.
Journal: Reviews in endocrine & metabolic disorders
Published: May 21, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Sbardella's expertise for a condition
ConditionClose
      View All 17 Advanced Conditions
      View All 44 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile